MindMed's Set to Pass a Psychological Market Test
moneymorning.com3 Comments
This is actually a really interesting stock and I think it has the potential to go further than the $10 breakout the author is talking about. I have a feeling it'll be one of the newer biotech darlings
Yup! With psychedelics starting to get their day in their usage for treatments, this one seems poised to be at the forefront of those therapies.
Could definitely be a good bet but I'd still watch for its biggest competitors like GSK.